Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Finasteride, a hair loss drug, is linked to increased suicidal thoughts, particularly when used for hair loss.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Procare is bioequivalent to Proscar.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

PCOS is common in Brazilian women and linked to metabolic and reproductive issues.

Less than 10% of nursing students have PCOS, but many show symptoms and poor health habits, needing more education and yearly check-ups.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

PCOS significantly affects women's quality of life, causing anxiety and social issues, and requires comprehensive care.

The guideline offers recommendations for diagnosing and managing PCOS and its complications.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Patients with Complete Androgen Insensitivity Syndrome need psychological support and multidisciplinary care for complex treatment decisions.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Cronkhite-Canada syndrome can sometimes show unusual colonic adenomatous polyps.

Many young women are unaware of PCOS symptoms, and poor diets worsen their menstrual cycles.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

PCOS diagnosis and management have improved with new guidelines for personalized care.

19.5% of young college girls have PCOS, highlighting the need for early screening and intervention.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.